ES2493765T3 - Sistemas y métodos para el análisis automatizado de células y tejidos - Google Patents

Sistemas y métodos para el análisis automatizado de células y tejidos Download PDF

Info

Publication number
ES2493765T3
ES2493765T3 ES02739157.2T ES02739157T ES2493765T3 ES 2493765 T3 ES2493765 T3 ES 2493765T3 ES 02739157 T ES02739157 T ES 02739157T ES 2493765 T3 ES2493765 T3 ES 2493765T3
Authority
ES
Spain
Prior art keywords
image
defined area
pixel
pixel location
intensity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES02739157.2T
Other languages
English (en)
Inventor
David L. Rimm
Robert L. Camp
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yale University
Original Assignee
Yale University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yale University filed Critical Yale University
Application granted granted Critical
Publication of ES2493765T3 publication Critical patent/ES2493765T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G06COMPUTING OR CALCULATING; COUNTING
    • G06TIMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T7/00Image analysis
    • G06T7/0002Inspection of images, e.g. flaw detection
    • G06T7/0012Biomedical image inspection
    • G06T7/0014Biomedical image inspection using an image reference approach
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/645Specially adapted constructive features of fluorimeters
    • G01N21/6456Spatial resolved fluorescence measurements; Imaging
    • G01N21/6458Fluorescence microscopy
    • GPHYSICS
    • G02OPTICS
    • G02BOPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B21/00Microscopes
    • G02B21/36Microscopes arranged for photographic purposes or projection purposes or digital imaging or video purposes including associated control and data processing arrangements
    • G02B21/365Control or image processing arrangements for digital or video microscopes
    • G02B21/367Control or image processing arrangements for digital or video microscopes providing an output produced by processing a plurality of individual source images, e.g. image tiling, montage, composite images, depth sectioning, image comparison
    • GPHYSICS
    • G06COMPUTING OR CALCULATING; COUNTING
    • G06TIMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T7/00Image analysis
    • G06T7/0002Inspection of images, e.g. flaw detection
    • G06T7/0012Biomedical image inspection
    • GPHYSICS
    • G06COMPUTING OR CALCULATING; COUNTING
    • G06TIMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T7/00Image analysis
    • G06T7/40Analysis of texture
    • G06T7/41Analysis of texture based on statistical description of texture
    • GPHYSICS
    • G06COMPUTING OR CALCULATING; COUNTING
    • G06VIMAGE OR VIDEO RECOGNITION OR UNDERSTANDING
    • G06V20/00Scenes; Scene-specific elements
    • G06V20/60Type of objects
    • G06V20/69Microscopic objects, e.g. biological cells or cellular parts
    • GPHYSICS
    • G02OPTICS
    • G02BOPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B21/00Microscopes
    • G02B21/16Microscopes adapted for ultraviolet illumination ; Fluorescence microscopes
    • GPHYSICS
    • G06COMPUTING OR CALCULATING; COUNTING
    • G06TIMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T2207/00Indexing scheme for image analysis or image enhancement
    • G06T2207/20Special algorithmic details
    • G06T2207/20036Morphological image processing
    • GPHYSICS
    • G06COMPUTING OR CALCULATING; COUNTING
    • G06TIMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T2207/00Indexing scheme for image analysis or image enhancement
    • G06T2207/20Special algorithmic details
    • G06T2207/20092Interactive image processing based on input by user
    • G06T2207/20101Interactive definition of point of interest, landmark or seed
    • GPHYSICS
    • G06COMPUTING OR CALCULATING; COUNTING
    • G06TIMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T2207/00Indexing scheme for image analysis or image enhancement
    • G06T2207/20Special algorithmic details
    • G06T2207/20212Image combination
    • G06T2207/20221Image fusion; Image merging
    • GPHYSICS
    • G06COMPUTING OR CALCULATING; COUNTING
    • G06TIMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T2207/00Indexing scheme for image analysis or image enhancement
    • G06T2207/30Subject of image; Context of image processing
    • G06T2207/30004Biomedical image processing
    • G06T2207/30024Cell structures in vitro; Tissue sections in vitro
    • GPHYSICS
    • G06COMPUTING OR CALCULATING; COUNTING
    • G06TIMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T2207/00Indexing scheme for image analysis or image enhancement
    • G06T2207/30Subject of image; Context of image processing
    • G06T2207/30004Biomedical image processing
    • G06T2207/30072Microarray; Biochip, DNA array; Well plate
    • GPHYSICS
    • G06COMPUTING OR CALCULATING; COUNTING
    • G06TIMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T2207/00Indexing scheme for image analysis or image enhancement
    • G06T2207/30Subject of image; Context of image processing
    • G06T2207/30004Biomedical image processing
    • G06T2207/30096Tumor; Lesion

Landscapes

  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • General Health & Medical Sciences (AREA)
  • Theoretical Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Multimedia (AREA)
  • Analytical Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Quality & Reliability (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Optics & Photonics (AREA)
  • Probability & Statistics with Applications (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Image Processing (AREA)
  • Image Analysis (AREA)

Abstract

Un método puesto en práctica por ordenador para localizar y cuantificar un biomarcador particular en muestras de tejido que contienen células, y el método comprende: a) usar un dispositivo óptico de formación de imágenes para obtener: i) una primera imagen de una célula con una primera tinción que es selectiva para una primera área definida dentro de la célula; ii) una segunda imagen de la célula con una segunda tinción que es selectiva para un biomarcador; y iii) una tercera imagen de la célula con una tercera tinción que es selectiva para una segunda área definida dentro de la célula, en la que cada imagen está compuesta de localizaciones de píxeles; b) leer la intensidad de píxel en cada localización de píxel de la primera imagen y la tercera imagen y comparar cada valor de intensidad con un valor de intensidad umbral predeterminado; c) asignar cada localización de píxel en la primera imagen y la tercera imagen a la primera área definida, la segunda área definida, o una tercera área definida, en el que, para cada localización de píxel, si el valor de intensidad de píxel en la localización de píxel solamente en la primera imagen es mayor que el valor de intensidad umbral respectivo, la localización de píxel se asigna a la primera área definida, si el valor de intensidad de píxel en la localización de píxel solamente en la tercera imagen es mayor que el valor de intensidad umbral respectivo, la localización de píxel se asigna a la segunda área definida, si los valores de intensidad de píxel en la localización de píxel tanto en la primera imagen como en la tercera imagen están por debajo de los valores de intensidad umbral respectivos, la localización de píxel se asigna a la tercera área definida, y si los valores de intensidad de píxel en la localización de píxel tanto en la primera imagen como en la tercera imagen son mayores que los valores de intensidad umbral respectivos, los valores de intensidad de píxel se comparan y la localización de píxel se asigna al área definida que corresponde a la imagen que tiene el mayor valor de intensidad de píxel en la localización de píxel; d) determinar la cantidad de intensidad de la primera área definida incorrectamente asignada a la segunda área definida y la cantidad de intensidad de la segunda área definida incorrectamente asignada a la primera área definida y reasignar las localizaciones de píxeles a la primera área definida o la segunda área definida respecto de una proporción ponderada de intensidad de la primera área definida respecto de la segunda área definida, y la ponderación se determina mediante un factor que se incrementa de manera iterativa hasta que la cantidad de localizaciones de píxeles incorrectamente asignadas es menor del 5%; e) comparar la segunda imagen con la primera y la tercera imágenes para identificar las localizaciones de píxeles en la segunda imagen que están dentro de la primera área definida o la segunda área definida; y f) sumar los valores de intensidad de las localizaciones de píxeles en la segunda imagen asignadas a áreas definidas similares para localizar y cuantificar así el biomarcador en las muestras de tejido que contienen células.

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6
imagen7
imagen8
imagen9
imagen10
imagen11
imagen12
imagen13
imagen14

Claims (1)

  1. imagen1
    imagen2
    imagen3
    imagen4
    imagen5
    imagen6
    imagen7
ES02739157.2T 2001-04-20 2002-04-19 Sistemas y métodos para el análisis automatizado de células y tejidos Expired - Lifetime ES2493765T3 (es)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US28515501P 2001-04-20 2001-04-20
US285155P 2001-04-20
US33472301P 2001-10-31 2001-10-31
US334723P 2001-10-31
US62308 2002-02-01
US10/062,308 US7219016B2 (en) 2001-04-20 2002-02-01 Systems and methods for automated analysis of cells and tissues
PCT/US2002/012084 WO2002086498A1 (en) 2001-04-20 2002-04-19 Systems and methods for automated analysis of cells and tissues

Publications (1)

Publication Number Publication Date
ES2493765T3 true ES2493765T3 (es) 2014-09-12

Family

ID=27370253

Family Applications (1)

Application Number Title Priority Date Filing Date
ES02739157.2T Expired - Lifetime ES2493765T3 (es) 2001-04-20 2002-04-19 Sistemas y métodos para el análisis automatizado de células y tejidos

Country Status (7)

Country Link
US (8) US7219016B2 (es)
EP (1) EP1390747B1 (es)
JP (4) JP4433674B2 (es)
AU (1) AU2002311827B9 (es)
CA (1) CA2442604C (es)
ES (1) ES2493765T3 (es)
WO (1) WO2002086498A1 (es)

Families Citing this family (200)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5161052B2 (ja) * 2008-12-04 2013-03-13 オリンパス株式会社 顕微鏡システム、標本観察方法およびプログラム
US7391929B2 (en) * 2000-02-11 2008-06-24 Sony Corporation Masking tool
EP1373896A2 (en) * 2001-03-12 2004-01-02 MonoGen, Inc. Cell-based detection and differentiation of disease states
US20030190602A1 (en) * 2001-03-12 2003-10-09 Monogen, Inc. Cell-based detection and differentiation of disease states
US7219016B2 (en) 2001-04-20 2007-05-15 Yale University Systems and methods for automated analysis of cells and tissues
US6989276B2 (en) 2001-05-10 2006-01-24 Battelle Energy Alliance, Llc Rapid classification of biological components
USRE44031E1 (en) 2001-05-10 2013-02-26 Battelle Energy Alliance, Llc Antibody profiling sensitivity through increased reporter antibody layering
USRE46351E1 (en) 2001-05-10 2017-03-28 Battelle Energy Alliance, Llc Antibody profiling sensitivity through increased reporter antibody layering
US7695919B2 (en) * 2001-05-10 2010-04-13 Battelle Energy Alliance, Llc Antibody profiling sensitivity through increased reporter antibody layering
GB0130862D0 (en) * 2001-12-22 2002-02-06 P W Allen & Company Ltd Method of examining potential cellular abnormalities
EP1541330B1 (en) 2002-06-18 2010-11-03 AMADA COMPANY, Ltd. Press machine with a servo-drive system
GB0229734D0 (en) * 2002-12-23 2003-01-29 Qinetiq Ltd Grading oestrogen and progesterone receptors expression
US7056673B2 (en) * 2003-04-25 2006-06-06 Janssen Pharmaceutica N.V. Preservation of RNA in a biological sample
JP2004347454A (ja) * 2003-05-22 2004-12-09 Mitsubishi Rayon Co Ltd シェーディング補正方法
US8068988B2 (en) * 2003-09-08 2011-11-29 Ventana Medical Systems, Inc. Method for automated processing of digital images of tissue micro-arrays (TMA)
WO2005027015A2 (en) 2003-09-10 2005-03-24 Bioimagene, Inc. Method and system for quantitatively analyzing biological samples
US7805003B1 (en) 2003-11-18 2010-09-28 Adobe Systems Incorporated Identifying one or more objects within an image
UA86063C2 (ru) 2004-05-03 2009-03-25 Хермес Біосайенсез, Інк. Липосомы для снабжения лекарств
WO2005114578A1 (en) * 2004-05-21 2005-12-01 Bioimagene, Inc. Method and system for automated quantitation of tissue micro-array (tma) digital image analysis
AU2005285246B2 (en) * 2004-09-03 2011-07-21 The Scripps Research Institute Isolated lineage negative hematopoietic stem cells and methods of treatment therewith
EP1811017B1 (en) * 2004-11-09 2013-01-09 Kaneka Corporation Cell cultivating device, image processing device and cell detecting system
US8116984B2 (en) * 2004-11-19 2012-02-14 Trillium Diagnostics, Llc Software integrated cytometric assay for quantification of the human polymorphonuclear leukocyte FcγRI receptor (CD64)
WO2006133460A2 (en) * 2005-06-09 2006-12-14 Yale University Methods for diagnosing and treating breast cancer based on a her/er ratio
CA2632188A1 (en) * 2005-11-10 2007-05-24 Rosetta Inpharmatics Llc Discover biological features using composite images
EP1967886A4 (en) * 2005-12-27 2011-01-05 Olympus Corp DEVICE AND METHOD FOR RECORDING AN IMAGE OF A SAMPLE FROM AN ORGANISM
US20090170091A1 (en) * 2006-01-17 2009-07-02 Kenneth Giuliano Method For Predicting Biological Systems Responses
US8131112B1 (en) * 2006-01-23 2012-03-06 Sandia Corporation Method for detecting cancer in a single cell using mitochondrial correlation microscopy
US20070191675A1 (en) * 2006-02-13 2007-08-16 Joel Gerardo Diaz Sanchez Actinic light colposcope and method to detect lesions in the lower female genital tract produced by human papilloma virus using an actinic light colposcope
CA2649877A1 (en) 2006-04-24 2007-12-21 Gloucester Pharmaceuticals Gemcitabine combination therapy
WO2007130677A2 (en) 2006-05-05 2007-11-15 Yale University Use of subcellular localization profiles as prognostic or predictive indicators
US8114615B2 (en) 2006-05-17 2012-02-14 Cernostics, Inc. Method for automated tissue analysis
EP2032983A2 (en) * 2006-05-24 2009-03-11 Cellumen, Inc. Method for modeling a disease
WO2007146730A2 (en) 2006-06-08 2007-12-21 Gloucester Pharmaceuticals Deacetylase inhibitor therapy
WO2007144386A1 (de) * 2006-06-14 2007-12-21 Evotec Technologies Gmbh Verfahren zur aufnahme und auswertung von bildsequenzen
EP2046971B1 (en) * 2006-06-30 2012-04-04 University Of Southern California Quantifiable internal reference standards for immunohistochemistry and uses thereof
CA2657324A1 (en) * 2006-07-13 2008-01-17 Yale University Methods for making cancer prognoses based on subcellular localization of biomarkers
US20080032321A1 (en) * 2006-08-07 2008-02-07 General Electric Company System and methods for analyzing images of tissue samples
US8131476B2 (en) * 2006-08-07 2012-03-06 General Electric Company System and method for co-registering multi-channel images of a tissue micro array
US8060348B2 (en) * 2006-08-07 2011-11-15 General Electric Company Systems for analyzing tissue samples
BRPI0716478A2 (pt) * 2006-09-05 2014-03-18 Veridex Llc Métodos para classificação de imagens celulares
JP5021254B2 (ja) * 2006-09-06 2012-09-05 オリンパス株式会社 顕微鏡装置の制御方法、顕微鏡装置
WO2008060483A2 (en) * 2006-11-10 2008-05-22 Cellumen, Inc. Protein-protein interaction biosensors and methods of use thereof
US9697582B2 (en) 2006-11-16 2017-07-04 Visiopharm A/S Methods for obtaining and analyzing images
US7741045B2 (en) * 2006-11-16 2010-06-22 General Electric Company Sequential analysis of biological samples
WO2010017822A1 (en) * 2008-08-15 2010-02-18 Visiopharm A/S A method and a system for determining a target in a biological sample by image analysis
US7629125B2 (en) * 2006-11-16 2009-12-08 General Electric Company Sequential analysis of biological samples
US9201063B2 (en) * 2006-11-16 2015-12-01 General Electric Company Sequential analysis of biological samples
US9008378B2 (en) 2006-12-20 2015-04-14 The Board Of Trustees Of The Leland Stanford Junior University Arrangement and imaging of biological samples
US8131035B2 (en) * 2007-02-05 2012-03-06 Siemens Healthcare Diagnostics Inc. Cell analysis using isoperimetric graph partitioning
US9355445B2 (en) * 2007-03-01 2016-05-31 Nec Corporation Breast cancer pathological image diagnosis support system, breast cancer pathological image diagnosis support method, and recording medium recording breast cancer pathological image diagnosis support program
US20080286881A1 (en) * 2007-05-14 2008-11-20 Apel William A Compositions and methods for combining report antibodies
ES2374686T3 (es) * 2007-05-14 2012-02-21 Historx, Inc. Separación en compartimentos por caracterización de píxel usando agrupamiento de datos de imágenes.
US8351674B2 (en) * 2007-05-31 2013-01-08 Battelle Energy Alliance, Llc Image portion identification methods, image parsing methods, image parsing systems, and articles of manufacture
EP2162728B1 (en) * 2007-06-15 2016-07-27 Novartis AG Microscope system and method for obtaining standardized sample data
WO2009005715A1 (en) * 2007-06-29 2009-01-08 Yale University Methods for a predictive diagnostic test for tamoxifen
WO2009005816A1 (en) * 2007-07-03 2009-01-08 Yale University Methods for differential diagnosis of melanocytic lesions
CA2604317C (en) 2007-08-06 2017-02-28 Historx, Inc. Methods and system for validating sample images for quantitative immunoassays
CA2596204C (en) * 2007-08-07 2019-02-26 Historx, Inc. Method and system for determining an optimal dilution of a reagent
WO2009029810A1 (en) * 2007-08-31 2009-03-05 Historx, Inc. Automatic exposure time selection for imaging tissue
JP5040597B2 (ja) * 2007-11-06 2012-10-03 日本電気株式会社 評価システム、評価方法および評価プログラム
US8031924B2 (en) * 2007-11-30 2011-10-04 General Electric Company Methods and systems for removing autofluorescence from images
US8139831B2 (en) * 2007-12-06 2012-03-20 Siemens Aktiengesellschaft System and method for unsupervised detection and gleason grading of prostate cancer whole mounts using NIR fluorscence
CN101952762B (zh) 2008-01-02 2012-11-28 加利福尼亚大学董事会 高数值孔径远程显微镜设备
US8070398B2 (en) * 2008-02-19 2011-12-06 Irwin Industrial Tool Company Multi-blade self feed bit
US8189884B2 (en) * 2008-03-26 2012-05-29 General Electric Company Methods for assessing molecular expression of subcellular molecules
US8135187B2 (en) 2008-03-26 2012-03-13 General Electric Company Method and apparatus for removing tissue autofluorescence
AU2009293380B2 (en) * 2008-09-16 2016-05-19 Novartis Ag Reproducible quantification of biomarker expression
WO2010118324A2 (en) 2009-04-09 2010-10-14 Nuclea Biotechnologies, LLC Antibodies against fatty acid synthase
US8685891B2 (en) 2009-08-27 2014-04-01 Nuclea Biotechnologies, Inc. Method and assay for determining FAS expression
US8969009B2 (en) * 2009-09-17 2015-03-03 Vicki S. Thompson Identification of discriminant proteins through antibody profiling, methods and apparatus for identifying an individual
US9410965B2 (en) * 2009-09-17 2016-08-09 Battelle Energy Alliance, Llc Identification of discriminant proteins through antibody profiling, methods and apparatus for identifying an individual
US9677125B2 (en) * 2009-10-21 2017-06-13 General Electric Company Detection of plurality of targets in biological samples
US9001200B2 (en) 2010-01-12 2015-04-07 Bio-Rad Laboratories, Inc. Cell characterization using multiple focus planes
US10702251B2 (en) 2010-02-25 2020-07-07 Robin Medical Inc. Cryogenic biopsy system and method
US9566047B2 (en) * 2010-02-25 2017-02-14 Erez Nevo Cryogenic biopsy system and method
CN102792147B (zh) * 2010-03-10 2015-05-13 贝克曼考尔特公司 在颗粒分析器中产生脉冲参数
CA2804795A1 (en) 2010-07-12 2012-01-19 Nicholas Vrolijk Romidepsin solid forms and uses thereof
WO2012019133A1 (en) 2010-08-05 2012-02-09 Cambridge Research & Instrumentation, Inc. Enhancing visual assessment of samples
US8859502B2 (en) 2010-09-13 2014-10-14 Celgene Corporation Therapy for MLL-rearranged leukemia
US10024796B2 (en) 2010-10-29 2018-07-17 President And Fellows Of Harvard College Nucleic acid nanostructure barcode probes
WO2012065117A2 (en) * 2010-11-12 2012-05-18 William Marsh Rice University Oral cancer point of care diagnostics
US20130344510A1 (en) 2010-12-03 2013-12-26 Uti Limited Partnership Identification of cancer patients likely to benefit from radiation therapy
US9092850B2 (en) * 2011-01-21 2015-07-28 Carnegie Mellon University Identifying location biomarkers
KR20120102447A (ko) * 2011-03-08 2012-09-18 삼성전자주식회사 진단장치 및 방법
US10018631B2 (en) 2011-03-17 2018-07-10 Cernostics, Inc. Systems and compositions for diagnosing Barrett's esophagus and methods of using the same
JP5372068B2 (ja) * 2011-05-20 2013-12-18 キヤノン株式会社 撮像システム、画像処理装置
CA2852757A1 (en) * 2011-10-17 2013-04-25 Nuclea Biotechnologies, Inc. Predictive biomarkers for breast cancer
KR101828828B1 (ko) 2011-10-24 2018-03-29 할로자임, 아이엔씨 항-히알루로난 제제 치료를 위한 동반 진단 및 이의 사용 방법
US20130143237A1 (en) * 2011-11-29 2013-06-06 Genentech, Inc. Compositions and methods for prostate cancer analysis
CA2867144C (en) 2012-03-27 2019-07-02 Ventana Medical Systems, Inc. Signaling conjugates and methods of use
AU2013240137B2 (en) 2012-03-30 2017-04-20 Leica Microsystems Cms Gmbh Methods for generating an image of a biological sample
JP5924406B2 (ja) * 2012-04-23 2016-05-25 日本電気株式会社 画像計測装置、画像計測方法、および、画像計測用プログラム
JP5870851B2 (ja) * 2012-05-29 2016-03-01 ソニー株式会社 情報処理装置、情報処理方法、及びプログラム
AU2013202947B2 (en) 2012-06-13 2016-06-02 Ipsen Biopharm Ltd. Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan
US9717724B2 (en) 2012-06-13 2017-08-01 Ipsen Biopharm Ltd. Methods for treating pancreatic cancer using combination therapies
KR20150023808A (ko) * 2012-06-20 2015-03-05 메리맥 파마슈티컬즈, 인크. 조직 절편 내 단일 세포에서의 마커 정량
AU2013202506B2 (en) 2012-09-07 2015-06-18 Celgene Corporation Resistance biomarkers for hdac inhibitors
WO2014043253A1 (en) * 2012-09-11 2014-03-20 Neogenomics Laboratories Automated fish reader using learning machines
WO2014062856A1 (en) 2012-10-16 2014-04-24 Halozyme, Inc. Hypoxia and hyaluronan and markers thereof for diagnosis and monitoring of diseases and conditions and related methods
AU2013202507B9 (en) 2012-11-14 2015-08-13 Celgene Corporation Inhibition of drug resistant cancer cells
AU2013353154B2 (en) * 2012-11-28 2016-06-23 Japan Science And Technology Agency Cell monitoring device, cell monitoring method and program thereof.
ES2804300T3 (es) 2013-03-12 2021-02-05 Ventana Med Syst Inc Microscopía mejorada digitalmente para histología multiplexada
EP2972376B1 (en) 2013-03-15 2018-12-05 Eisai Inc. Methods for determining prognosis of colorectal cancer
US9064304B2 (en) 2013-03-18 2015-06-23 General Electric Company Image quality assessment of microscopy images
WO2014172345A2 (en) * 2013-04-15 2014-10-23 Massachusetts Institute Of Technology Fully automated system and method for image segmentation and quality control of protein microarrays
WO2014197622A2 (en) 2013-06-04 2014-12-11 The Regents Of The University Of California Liver-mimetic device and method for simulation of hepatic function using such device
KR20160039229A (ko) 2013-07-30 2016-04-08 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 정량적 dna-기반 영상화 및 초해상도 영상화
EP3039477B1 (en) 2013-08-26 2021-10-20 S.D. Sight Diagnostics Ltd. Digital microscopy systems, methods and computer program products
AU2014333927A1 (en) * 2013-10-07 2016-03-03 Ventana Medical Systems, Inc. Systems and methods for comprehensive multi-assay tissue analysis
GB201318598D0 (en) * 2013-10-21 2013-12-04 Univ Leicester Improvements in or relating to super-resolution microscopy
NZ630311A (en) 2013-12-27 2016-03-31 Celgene Corp Romidepsin formulations and uses thereof
WO2015117067A1 (en) * 2014-01-31 2015-08-06 The General Hospital Corporation Dba Massachusetts General Hospital Methods of treating and imaging tumor micrometastases using photoactivatable immunoconjugates
WO2015124777A1 (en) * 2014-02-21 2015-08-27 Ventana Medical Systems, Inc. Medical image analysis for identifying biomarker-positive tumor cells
AU2015220783B2 (en) * 2014-02-24 2021-02-04 Ventana Medical Systems, Inc. Methods, kits, and systems for scoring the immune response to cancer by simultaneous detection of CD3, CD8, CD20, and FoxP3
KR102313982B1 (ko) 2014-03-11 2021-10-18 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 프로그램가능한 핵산 프로브를 이용한 고처리량 고도 다중 영상화
US20170016911A1 (en) * 2014-03-24 2017-01-19 Konica Minolta, Inc. Method for quantifying biological material based on multiple immunostaining
US9683939B2 (en) 2014-05-12 2017-06-20 Cellomics, Inc. Automated imaging of chromophore labeled samples
HUE043847T2 (hu) 2014-08-28 2019-09-30 Halozyme Inc Hialuronán-lebontó enzimmel és egy immun checkpoint inhibitorral végzett kombinációs terápia
US10351819B2 (en) 2014-09-16 2019-07-16 The Regents Of The University Of California Method for fabrication of microwells for controlled formation of 3-dimensional multicellular-shapes
JP6499506B2 (ja) * 2015-04-30 2019-04-10 富士フイルム株式会社 撮像装置および方法並びに撮像制御プログラム
US11318131B2 (en) 2015-05-18 2022-05-03 Ipsen Biopharm Ltd. Nanoliposomal irinotecan for use in treating small cell lung cancer
KR102557419B1 (ko) 2015-08-07 2023-07-19 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 단백질-단백질 상호작용의 초해상도 영상화
PL3337467T3 (pl) 2015-08-20 2021-06-14 Ipsen Biopharm Ltd. Terapia skojarzona z zastosowaniem liposomalnego irynotekanu i inhibitora parp do leczenia nowotworu
IL257149B2 (en) 2015-08-21 2024-11-01 Ipsen Biopharm Ltd Methods for treating metastatic pancreatic cancer using combination therapies comprising liposomal irinotecan and oxaliplatin
ES2955775T3 (es) 2015-08-27 2023-12-07 Inst Nat Sante Rech Med Métodos para predecir el tiempo de supervivencia de pacientes que padecen cáncer de pulmón
WO2017060397A1 (en) 2015-10-09 2017-04-13 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for predicting the survival time of subjects suffering from melanoma metastases
MX382522B (es) 2015-10-16 2025-03-13 Ipsen Biopharm Ltd Composiciones farmaceuticas estabilizantes de camptotecina.
WO2017067944A1 (en) 2015-10-19 2017-04-27 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for predicting the survival time of subjects suffering from triple negative breast cancer
EP3719143B1 (en) * 2015-10-23 2023-07-26 Novartis AG Method of deriving a value for percent biomarker positivity for selected cells present in a field of view
EP3365682B1 (en) * 2015-10-23 2020-10-07 Novartis AG System for deriving cell-to-cell spatial proximities
ES2877178T3 (es) 2015-10-23 2021-11-16 Novartis Ag Procesos informáticos tras una versión mejorada de AQUA
EP3374389A1 (en) 2015-11-13 2018-09-19 INSERM (Institut National de la Santé et de la Recherche Médicale) Anti- nkg2d single domain antibodies and uses thereof
EP3380840B1 (en) 2015-11-25 2020-08-19 Cernostics, Inc. Methods of predicting progression of barrett's esophagus
WO2017118634A1 (en) 2016-01-04 2017-07-13 INSERM (Institut National de la Santé et de la Recherche Médicale) Use of pd-1 and tim-3 as a measure for cd8+ cells in predicting and treating renal cell carcinoma
WO2017129769A1 (en) 2016-01-28 2017-08-03 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for enhancing the potency of the immune checkpoint inhibitors
EP3203413A1 (en) * 2016-02-08 2017-08-09 Ecole Polytechnique Federale De Lausanne (Epfl) Method for quantitative measurement of a biomarker by in situ immunofluorescence and uses thereof
WO2017202962A1 (en) 2016-05-24 2017-11-30 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of non small cell lung cancer (nsclc) that coexists with chronic obstructive pulmonary disease (copd)
WO2018011107A1 (en) 2016-07-11 2018-01-18 INSERM (Institut National de la Santé et de la Recherche Médicale) Use of er-alpha 46 in methods and kits for assessing the status of breast cancer
WO2018046736A1 (en) 2016-09-12 2018-03-15 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for predicting the survival time of patients suffering from cancer
JP6646552B2 (ja) * 2016-09-13 2020-02-14 株式会社日立ハイテクノロジーズ 画像診断支援装置、画像診断支援方法及び試料分析システム
EP3535026A1 (en) 2016-11-02 2019-09-11 Ipsen Biopharm Limited Treating gastric cancer using combination therapies comprising liposomal irinotecan, oxaliplatin, 5-fluoruracil (and leucovorin)
IL266652B2 (en) * 2016-11-16 2024-11-01 Nanosomix Inc Quantification of subpopulations of exosomes and diagnosis of neurodegenerative disorders
JP2020513796A (ja) 2016-11-16 2020-05-21 ユニバーシティ オブ ワシントンUniversity of Washington サイクリック蛍光イメージングのためのシステムおよび方法
WO2018107054A1 (en) 2016-12-09 2018-06-14 Ultivue, Inc. Improved methods for multiplex imaging using labeled nucleic acid imaging agents
WO2018122249A1 (en) 2016-12-28 2018-07-05 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for predicting the survival time of patients suffering from a microsatellite stable colorectal cancer
WO2018122245A1 (en) 2016-12-28 2018-07-05 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods of predicting the survival time of patients suffering from cms3 colorectal cancer
WO2019043138A1 (en) 2017-09-01 2019-03-07 INSERM (Institut National de la Santé et de la Recherche Médicale) METHOD FOR PREDICTING OUTCOME OF CANCER
JP6404425B2 (ja) * 2017-09-27 2018-10-10 株式会社日立エルジーデータストレージ 光画像計測装置
WO2019089858A2 (en) 2017-11-01 2019-05-09 Juno Therapeutics, Inc. Methods of assessing or monitoring a response to a cell therapy
WO2019101871A1 (en) 2017-11-23 2019-05-31 Inserm (Institut National De La Sante Et De La Recherche Medicale) A new marker for predicting the sensitivity to pi3k inhibitors
EP4285838B1 (en) 2017-12-05 2025-08-13 Devicor Medical Products, Inc. Biopsy device with applied imaging
US11314994B2 (en) * 2018-01-30 2022-04-26 Riken Mask structure optimization device, mask structure optimization method, and program
EP3765085A1 (en) 2018-03-12 2021-01-20 Université de Paris Use of caloric restriction mimetics for potentiating chemo-immunotherapy for the treatment of cancers
US11515009B2 (en) 2018-03-19 2022-11-29 International Business Machines Corporation Biomarker quantification in a tissue sample
JP7084193B2 (ja) * 2018-04-10 2022-06-14 ザイオソフト株式会社 医用画像処理装置、医用画像処理方法、及び医用画像処理プログラム
JP2021521445A (ja) 2018-04-13 2021-08-26 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル 前立腺癌又は乳癌を患っている患者の転帰を予測するための及び処置のための方法
WO2019207030A1 (en) 2018-04-26 2019-10-31 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for predicting a response with an immune checkpoint inhibitor in a patient suffering from a lung cancer
CN108896363A (zh) * 2018-05-28 2018-11-27 杭州智微信息科技有限公司 一种骨髓涂片数字化的流程方法
WO2020048942A1 (en) 2018-09-04 2020-03-12 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for enhancing cytotoxic t lymphocyte-dependent immune responses
EP3853251A1 (en) 2018-09-19 2021-07-28 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical composition for the treatment of cancers resistant to immune checkpoint therapy
WO2020070053A1 (en) 2018-10-01 2020-04-09 INSERM (Institut National de la Santé et de la Recherche Médicale) Use of inhibitors of stress granule formation for targeting the regulation of immune responses
WO2020120592A1 (en) 2018-12-12 2020-06-18 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and compositions for predicting and treating melanoma
US20220047556A1 (en) 2018-12-17 2022-02-17 INSERM (Institut National de la Santé et de la Recherche Médicale) Use of sulconazole as a furin inhibitor
EP3906415A1 (en) 2019-01-03 2021-11-10 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for enhancing cd8+ t cell-dependent immune responses in subjects suffering from cancer
MX2021008396A (es) 2019-01-10 2021-11-04 Innovacorium Inc Composiciones de administración farmacéutica y sus usos.
JP7564122B2 (ja) 2019-03-29 2024-10-08 ラクテン・メディカル,インコーポレイテッド 光免疫療法のための方法および関連バイオマーカー
WO2020201362A2 (en) 2019-04-02 2020-10-08 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods of predicting and preventing cancer in patients having premalignant lesions
WO2020208060A1 (en) 2019-04-09 2020-10-15 INSERM (Institut National de la Santé et de la Recherche Médicale) Use of sk2 inhibitors in combination with immune checkpoint blockade therapy for the treatment of cancer
AU2020288603A1 (en) 2019-06-03 2021-12-16 Assistance Publique - Hôpitaux De Paris Methods for modulating a treatment regimen
US12523663B2 (en) 2019-06-04 2026-01-13 Inserm (Institut National De La Santé Et De La Rescherche Médicale) Use of CD9 as a biomarker and as a biotarget in glomerulonephritis or glomerulosclerosis
WO2021074391A1 (en) 2019-10-17 2021-04-22 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for diagnosing nasal intestinal type adenocarcinomas
US10670512B1 (en) 2019-10-18 2020-06-02 Center For Quantitative Cytometry Apparatus to perform intrinsic hyper-spectral flow cytometry
US10652484B1 (en) 2019-10-18 2020-05-12 Center For Quantitative Cytometry Method to obtain data cubes of low intensity intrinsic spectral images when imaging under high illumination conditions without the use of filters
EP4049176A1 (en) 2019-10-22 2022-08-31 S.D. Sight Diagnostics Ltd. Accounting for errors in optical measurements
EP4058806B1 (en) * 2019-11-11 2024-01-03 Miltenyi Biotec B.V. & Co. KG Serial multichannel microscopy
MX2022007123A (es) 2019-12-12 2022-07-11 S D Sight Diagnostics Ltd Analisis de un analito dispuesto dentro de un medio.
CN114787625B (zh) 2019-12-12 2026-01-13 思迪赛特诊断有限公司 检测血液样品中的血小板
WO2021116957A1 (en) * 2019-12-12 2021-06-17 S.D. Sight Diagnostics Ltd Off-focus microscopic images of a sample
WO2021144426A1 (en) 2020-01-17 2021-07-22 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and compositions for treating melanoma
EP4110955A1 (en) 2020-02-28 2023-01-04 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for diagnosing, prognosing and managing treatment of breast cancer
US11551360B2 (en) 2020-04-28 2023-01-10 QATAR UNIVERSITY, Office of Academic Research Device and method for cancer detection
EP4153994B1 (en) * 2020-05-20 2025-11-12 Roche Diagnostics Hematology, Inc. Use of automated platforms for preparation of biomarker and romanowsky-type stained sample printed on a slide
US20230184639A1 (en) * 2020-05-29 2023-06-15 Sony Group Corporation Information processing device, information processing method, computer program, and target molecule detection system
CN115997123A (zh) 2020-06-30 2023-04-21 国家医疗保健研究所 用于预测实体癌患者在术前辅助治疗后复发和/或死亡风险的方法
JP7741831B2 (ja) 2020-06-30 2025-09-18 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル 術前補助療法及び根治手術後の固形がんを患っている患者の再発及び/又は死亡のリスクを予測するための方法
CN112201300B (zh) * 2020-10-23 2022-05-13 天津大学 基于深度图像特征和阈值学习策略的蛋白质亚细胞定位的方法
US20240175873A1 (en) 2021-03-23 2024-05-30 Institut National de la Santé et de la Recherche Médicale Methods for the diagnosis and treatment of t cell-lymphomas
WO2022229136A1 (en) 2021-04-27 2022-11-03 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for predicting the risk of lymph node metastasis and/or recurrence of patients suffering from a t1 cancer treated by endoscopic resection
EP4433802A4 (en) * 2021-11-17 2025-10-15 Becton Dickinson Co METHODS FOR REAL-TIME DYNAMIC ADJUSTMENT OF A DATA ACQUISITION PARAMETER IN A FLOW CYTOMETER
EP4472740A1 (en) 2022-01-31 2024-12-11 INSERM (Institut National de la Santé et de la Recherche Médicale) Cd38 as a biomarker and biotarget in t-cell lymphomas
US20250035635A1 (en) 2022-03-17 2025-01-30 Institut National De La Sante Et De La Recherche Medicale Methods for predicting response to an immunotherapeutic treatment in a patient with a cancer
JP2025514669A (ja) 2022-04-11 2025-05-09 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル T細胞悪性腫瘍の診断及び処置のための方法
WO2023198874A1 (en) 2022-04-15 2023-10-19 Institut National de la Santé et de la Recherche Médicale Methods for the diagnosis and treatment of t cell-lymphomas
WO2024003310A1 (en) 2022-06-30 2024-01-04 Institut National de la Santé et de la Recherche Médicale Methods for the diagnosis and treatment of acute lymphoblastic leukemia
JP2025526336A (ja) 2022-07-22 2025-08-13 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル T細胞悪性腫瘍におけるバイオマーカー及びバイオターゲットとしてのgarp
WO2024023283A1 (en) 2022-07-29 2024-02-01 Institut National de la Santé et de la Recherche Médicale Lrrc33 as a biomarker and biotarget in cutaneous t-cell lymphomas
EP4602372A1 (en) 2022-10-12 2025-08-20 Institut National de la Santé et de la Recherche Médicale Cd81 as a biomarker and biotarget in t-cell malignancies
WO2024153636A1 (en) 2023-01-17 2024-07-25 Institut National de la Santé et de la Recherche Médicale Vasorin as a biomarker and biotarget in nephrology
WO2025045894A1 (en) 2023-08-28 2025-03-06 Institut National de la Santé et de la Recherche Médicale Methods and kits for diagnosing cause of nephrotic syndrome and guiding therapy
WO2026013072A1 (en) 2024-07-09 2026-01-15 Institut National de la Santé et de la Recherche Médicale Methods for predicting the health state of a subject from fibroblasts

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US26420A (en) 1859-12-13 Improvement in seeding-machines
US4998284A (en) * 1987-11-17 1991-03-05 Cell Analysis Systems, Inc. Dual color camera microscope and methodology for cell staining and analysis
JP2628302B2 (ja) * 1987-04-14 1997-07-09 富士レビオ株式会社 凝集判定方法および装置
US5386819A (en) 1990-03-29 1995-02-07 Olympus Optical Co., Ltd. Method and apparatus for inhibiting a scattered component in a light having passed through an examined object
JP2852096B2 (ja) * 1990-03-29 1999-01-27 オリンパス光学工業株式会社 被検体通過中の散乱光成分抑制方法およびその装置
JPH0474950A (ja) * 1990-07-16 1992-03-10 Hitachi Ltd 発光検出型遺伝物質検出装置
US5936731A (en) 1991-02-22 1999-08-10 Applied Spectral Imaging Ltd. Method for simultaneous detection of multiple fluorophores for in situ hybridization and chromosome painting
US5784162A (en) 1993-08-18 1998-07-21 Applied Spectral Imaging Ltd. Spectral bio-imaging methods for biological research, medical diagnostics and therapy
US6026174A (en) * 1992-10-14 2000-02-15 Accumed International, Inc. System and method for automatically detecting malignant cells and cells having malignancy-associated changes
US6229649B1 (en) 1994-10-04 2001-05-08 The United States Of America As Represented By The Secretary Of The Air Force Pseudo deconvolution method of recovering a distorted optical image
JP2000501829A (ja) * 1995-07-19 2000-02-15 モルフォメトリックス テクノロジーズ インク. 画像解析用の多スペクトル分割
JP2000501184A (ja) * 1995-11-30 2000-02-02 クロマビジョン メディカル システムズ,インコーポレイテッド 生体標本の自動画像分析の方法および装置
US6151405A (en) * 1996-11-27 2000-11-21 Chromavision Medical Systems, Inc. System and method for cellular specimen grading
US5998151A (en) 1995-12-01 1999-12-07 The United States Of America As Represented By The Department Of Health And Human Services Methods for predicting the efficacy of a chemotherapeutic regimen for gastrointestinal cancers using antibodies specific for thymidylate synthase
US6165734A (en) 1995-12-12 2000-12-26 Applied Spectral Imaging Ltd. In-situ method of analyzing cells
US5989835A (en) 1997-02-27 1999-11-23 Cellomics, Inc. System for cell-based screening
US6727071B1 (en) * 1997-02-27 2004-04-27 Cellomics, Inc. System for cell-based screening
CA2311896A1 (en) * 1997-11-27 1999-06-24 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Improved method for the identification and characterization of interacting molecules using automation
JP4812937B2 (ja) * 1998-03-16 2011-11-09 ジーイー・ヘルスケア・バイオサイエンス・コーポレイション 共焦点顕微鏡イメージングシステム
US20030036855A1 (en) * 1998-03-16 2003-02-20 Praelux Incorporated, A Corporation Of New Jersey Method and apparatus for screening chemical compounds
US6492325B1 (en) * 1998-05-22 2002-12-10 Boys Town National Research Hospital Use of α1β1 integrin receptor inhibitors and TGF-β1 inhibitors in the treatment of kidney disease
US6337472B1 (en) 1998-10-19 2002-01-08 The University Of Texas System Board Of Regents Light imaging microscope having spatially resolved images
EP1131470A4 (en) 1998-10-28 2004-11-10 Vysis Inc CELLULAR NETWORKS AND METHODS FOR DETECTION AND USE OF GENETIC DISORDER MARKERS
US7666609B1 (en) 1998-12-01 2010-02-23 Shanghai Cp Guojian Pharmaceutical Co. Ltd. Method and composition for diagnosis of melanocytic lesions
US6351712B1 (en) * 1998-12-28 2002-02-26 Rosetta Inpharmatics, Inc. Statistical combining of cell expression profiles
US6251601B1 (en) 1999-02-02 2001-06-26 Vysis, Inc. Simultaneous measurement of gene expression and genomic abnormalities using nucleic acid microarrays
JP2000283853A (ja) * 1999-03-31 2000-10-13 Mitsubishi Electric Corp 波面センサ
AU4224400A (en) * 1999-04-08 2000-10-23 Sir Mortimer B. Davis Jewish General Hospital Quantitative assay for expression of genes in microarray
JP2002541494A (ja) * 1999-04-13 2002-12-03 クロマビジョン メディカル システムズ インコーポレイテッド 組織学的再構成と自動画像分析
AU7494900A (en) 1999-09-17 2001-04-17 Government of The United States of America, as represented by The Secretary Department of Health & Human Services, The National Institutes of Health, The Signal counting for in situ hybridization
WO2001022086A1 (en) 1999-09-24 2001-03-29 Jonathan Cohen A high-throughput system for evaluating the clinical utility of molecular targets in tissue samples
US7050087B2 (en) * 2000-12-06 2006-05-23 Bioview Ltd. Data acquisition and display system and method
US6466690C1 (en) 2000-12-19 2008-11-18 Bacus Res Lab Inc Method and apparatus for processing an image of a tissue sample microarray
AU2002324422A1 (en) 2001-02-21 2002-12-23 Amnis Corporation Method and apparatus for labeling and analyzing cellular components
US7219016B2 (en) 2001-04-20 2007-05-15 Yale University Systems and methods for automated analysis of cells and tissues
US7229774B2 (en) 2001-08-02 2007-06-12 Regents Of The University Of Michigan Expression profile of prostate cancer
FI20020653A0 (fi) 2002-04-05 2002-04-05 Taipale Automotive Oy Menetelmä ajoneuvoa ajavan henkilön sekä hänen ajotapansa tunnistamiseksi
US20060024692A1 (en) 2002-09-30 2006-02-02 Oncotherapy Science, Inc. Method for diagnosing non-small cell lung cancers
PT1733056E (pt) 2004-03-31 2013-08-29 Gen Hospital Corp Método para determinar a responsividade do cancro a tratamentos visando o receptor do factor de crescimento epidérmico
US7862995B2 (en) 2004-12-10 2011-01-04 Targeted Molecular Diagnostics Methods and materials for predicting responsiveness to treatment with dual tyrosine kinase inhibitor
WO2006113747A2 (en) 2005-04-19 2006-10-26 Prediction Sciences Llc Diagnostic markers of breast cancer treatment and progression and methods of use thereof
GB0524190D0 (en) * 2005-11-28 2006-01-04 Helse Stavanger Hf Method
CA2657324A1 (en) 2006-07-13 2008-01-17 Yale University Methods for making cancer prognoses based on subcellular localization of biomarkers
WO2008151072A1 (en) 2007-06-01 2008-12-11 The Regents Of The University Of California Multigene prognostic assay for lung cancer
WO2009005715A1 (en) 2007-06-29 2009-01-08 Yale University Methods for a predictive diagnostic test for tamoxifen
WO2009005816A1 (en) 2007-07-03 2009-01-08 Yale University Methods for differential diagnosis of melanocytic lesions
US20120245051A1 (en) 2009-10-13 2012-09-27 Rimm David L Objective, quantitative method to predict histological subtype in non-small cell lung cancer
WO2011053823A1 (en) 2009-10-30 2011-05-05 Yale University A melanoma prognostic model using tissue microarrays and genetic algorithms
EP2678676A4 (en) 2011-02-22 2014-10-29 Univ Yale PROTEIN EXPRESSION-BASED CLASSIFICATION FOR PREDICTING THE RECURRENCE OF ADENOCARCINOMENE

Also Published As

Publication number Publication date
JP2004532410A (ja) 2004-10-21
US7873480B2 (en) 2011-01-18
WO2002086498A8 (en) 2002-12-12
US8639450B2 (en) 2014-01-28
EP1390747A4 (en) 2009-07-08
US20080026420A1 (en) 2008-01-31
JP5290340B2 (ja) 2013-09-18
JP4873574B2 (ja) 2012-02-08
US8121794B2 (en) 2012-02-21
AU2002311827B2 (en) 2008-08-14
CA2442604C (en) 2011-06-07
US8036833B2 (en) 2011-10-11
JP4433674B2 (ja) 2010-03-17
JP2011117978A (ja) 2011-06-16
US20120329665A1 (en) 2012-12-27
US7219016B2 (en) 2007-05-15
AU2002311827B9 (en) 2009-03-12
US20080056553A1 (en) 2008-03-06
US10217219B2 (en) 2019-02-26
US20080046190A1 (en) 2008-02-21
US8185320B2 (en) 2012-05-22
JP2013092540A (ja) 2013-05-16
US20190259158A1 (en) 2019-08-22
EP1390747B1 (en) 2014-06-25
JP5612142B2 (ja) 2014-10-22
WO2002086498A1 (en) 2002-10-31
US20020177149A1 (en) 2002-11-28
JP2008139322A (ja) 2008-06-19
EP1390747A1 (en) 2004-02-25
CA2442604A1 (en) 2002-10-31
US11315250B2 (en) 2022-04-26
US20080013816A1 (en) 2008-01-17
US20140369586A1 (en) 2014-12-18

Similar Documents

Publication Publication Date Title
ES2493765T3 (es) Sistemas y métodos para el análisis automatizado de células y tejidos
Nicovich et al. Turning single-molecule localization microscopy into a quantitative bioanalytical tool
Rojo et al. Review of imaging solutions for integrated quantitative immunohistochemistry in the Pathology daily practice.
Löschberger et al. Correlative super-resolution fluorescence and electron microscopy of the nuclear pore complex with molecular resolution
Geissbuehler et al. Live-cell multiplane three-dimensional super-resolution optical fluctuation imaging
Lampe et al. Multi‐colour direct STORM with red emitting carbocyanines
CA2955156C (en) Systems and methods for generating fields of view
US20180329225A1 (en) Pattern Detection at Low Signal-To-Noise Ratio
CN102004091B (zh) 荧光图像产生方法和设备
CN116794819A (zh) 用于测定的光学器件、装置和系统
Varga et al. Quantification of DNA damage induced repair focus formation via super-resolution dSTORM localization microscopy
JP2013092540A5 (es)
CN103134782A (zh) 图像获取装置、图像获取方法和图像获取程序
Flormann et al. A novel universal algorithm for filament network tracing and cytoskeleton analysis
WO2016189469A1 (en) A method for medical screening and a system therefor
Dai et al. Deep learning–enabled filter-free fluorescence microscope
ES3033863T3 (en) Method for classifying a sequence of input images representing a particle in a sample over time
RU2540254C2 (ru) Способ и устройство для планирования сканирования с использованием ультрафиолетового излучения
Moeder et al. Quantitative, fluorescence-based in-situ assessment of protein expression
Dolled-Filhart et al. Automated analysis of tissue microarrays
US9785848B2 (en) Automated staining and segmentation quality control
D’Antuono Basic digital image acquisition, design, processing, analysis, management, and presentation
Owen et al. Fluorescence localization microscopy: The transition from concept to biological research tool
Yapp et al. Multiplexed 3D analysis of immune states and niches in human tissue
TW202046245A (zh) 獲得關於物件的區域的資訊的電腦化系統及方法